Being a leading cause of death in the global space, cancer is the main attraction of many scientists and researchers. The main objective of this attraction is linked to finding objective treatment methods for the disease. Mikhail Blagosklonny is a scientist who has initiated many projects dubbed towards finding treatment for cancer. The research scientist has made significant progress in finding treatment for the disease. He uses careful methods in research to arrive the possibilities of having better therapies for the cure. Blagosklonny has excellent research, a feature he owes to his academic background: an experienced specialist in biology, cancer treatment and research.
Coupled with the strong skills in academic work, Mikhail is set to find more treatment therapies and options for cancer. Mikhail has made numerous impacts to the world of cancer research. He harbors skills that no ordinary specialist would exude. Most importantly, he is passionate about bringing a new era of research and therapy to the world of medical practitioners. Mikhail has the determination to pursue cancer treatment in various platforms. His contributions to research and science cannot go unnoticed. He is revolutionizing the industry by investing in better treatment methods. He is inclined towards finding treatment methods that he considers useful.
One additional aspect that Mikhail has managed to thrive on is his editorial works. He is a senior editor for the research based journal, Oncotarget. This journal disseminates vital information concerning cancer and the right treatment therapies that should be utilized. Mikhail is also a publisher. He has written over 150 articles on cancer and diseases that are linked to age. Through the book chapters, he has been able to assist patients and doctors in many ways. Mikhail Blagosklonny has also co-authored many book chapters on research reviews, cellular and molecular insemination, the life cycle of a cancer cell and apoptosis.
To dig into his works, Mikhail Blagosklonny has proposed the TOR Signaling, a theory that explains aging and the diseases linked to it. Towards this end, Blagosklonny has proposed that TOR Signaling, also known as target of rapamycin, is essential in prolonging the cell life. This explains the inhibition of apoptosis and the delaying of autophagy. It is one way towards promoting cellular synthesis of proteins. TOR Signaling is vital when it comes to prolonging life. To Mikhail, these processes are vital in combating the aging process. As a result, the diseases linked to aging are barred. Mikhail also stated that there is a connection between autophagy and the multiplication of cell tumors. Towards this end, he stated that the over expression of the target of rapamycin has effects on cancerous tumors. Mikhail Blagosklonny is confident that diseases will be treated if the process of TOR Signaling is internalized. He also concludes that with the proper internalization of these processes, there will be a way forward in developing active and effective cancer treatments and drugs that will beat age based diseases.
Mikhail Blagosklonny has excellent academic credentials. His works go beyond research. Presently, he is a professor at Roswell Park Cancer Institute. He also edits Oncotarget and works as a key contributor.